RVMD – Revolution Medicines, Inc.
RVMD — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
7.37
Margin Of Safety %
Put/Call OI Ratio
0.55
EPS Next Q Diff
0.35
EPS Last/This Y
-2.12
EPS This/Next Y
2.27
Price
205.27
Target Price
216.4
Analyst Recom
1.1
Performance Q
43.95
Upside
-250.3%
Beta
1.4
Ticker: RVMD
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-13 | RVMD | 183.86 | 0.47 | 0.11 | 81340 |
| 2026-07-14 | RVMD | 184.92 | 0.47 | 0.78 | 81151 |
| 2026-07-15 | RVMD | 184.57 | 0.48 | 8.48 | 82037 |
| 2026-07-16 | RVMD | 179.28 | 0.48 | 0.26 | 82219 |
| 2026-07-17 | RVMD | 186.09 | 0.48 | 0.19 | 82383 |
| 2026-07-20 | RVMD | 181.15 | 0.52 | 0.30 | 65355 |
| 2026-07-21 | RVMD | 182.53 | 0.52 | 0.26 | 66034 |
| 2026-07-22 | RVMD | 182.96 | 0.51 | 0.58 | 66436 |
| 2026-07-23 | RVMD | 188.57 | 0.52 | 0.12 | 66573 |
| 2026-07-24 | RVMD | 189.16 | 0.50 | 0.14 | 67986 |
| 2026-07-27 | RVMD | 187.02 | 0.50 | 0.12 | 68405 |
| 2026-07-28 | RVMD | 184.02 | 0.49 | 0.88 | 68986 |
| 2026-07-29 | RVMD | 180.76 | 0.50 | 0.43 | 69512 |
| 2026-07-30 | RVMD | 192.1 | 0.51 | 0.24 | 69447 |
| 2026-07-31 | RVMD | 187.6 | 0.51 | 0.06 | 69504 |
| 2026-08-03 | RVMD | 182.43 | 0.50 | 0.40 | 69661 |
| 2026-08-04 | RVMD | 193.35 | 0.51 | 0.20 | 69863 |
| 2026-08-05 | RVMD | 197 | 0.51 | 0.20 | 70303 |
| 2026-08-06 | RVMD | 197.93 | 0.51 | 0.13 | 70654 |
| 2026-08-07 | RVMD | 204.23 | 0.55 | 0.37 | 67613 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-13 | RVMD | 183.85 | -55.2 | - | -8.04 |
| 2026-07-14 | RVMD | 184.94 | -55.2 | - | -8.04 |
| 2026-07-15 | RVMD | 184.43 | -55.2 | - | -8.04 |
| 2026-07-16 | RVMD | 179.13 | -55.2 | - | -8.04 |
| 2026-07-17 | RVMD | 186.08 | -55.9 | - | -8.03 |
| 2026-07-20 | RVMD | 180.39 | -55.9 | - | -8.03 |
| 2026-07-21 | RVMD | 183.28 | -55.9 | - | -8.03 |
| 2026-07-22 | RVMD | 182.99 | -55.9 | - | -8.02 |
| 2026-07-23 | RVMD | 188.75 | -55.9 | - | -8.02 |
| 2026-07-24 | RVMD | 189.11 | -56.5 | - | -8.06 |
| 2026-07-27 | RVMD | 188.18 | -56.5 | - | -8.06 |
| 2026-07-28 | RVMD | 183.86 | -57.0 | - | -8.07 |
| 2026-07-29 | RVMD | 180.87 | -57.0 | - | -8.07 |
| 2026-07-30 | RVMD | 191.96 | -57.0 | - | -8.07 |
| 2026-07-31 | RVMD | 187.59 | -57.0 | - | -8.07 |
| 2026-08-03 | RVMD | 182.27 | -57.0 | - | -8.07 |
| 2026-08-04 | RVMD | 182.27 | -57.0 | - | -8.07 |
| 2026-08-05 | RVMD | 196.96 | -57.0 | - | -8.07 |
| 2026-08-06 | RVMD | 197.81 | -57.0 | - | -8.07 |
| 2026-08-07 | RVMD | 205.27 | -57.0 | - | -8.07 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-13 | RVMD | -1.68 | -0.36 | 6.78 |
| 2026-07-14 | RVMD | -1.68 | -0.36 | 6.78 |
| 2026-07-15 | RVMD | -1.68 | -0.36 | 6.78 |
| 2026-07-16 | RVMD | -1.68 | -0.36 | 6.78 |
| 2026-07-17 | RVMD | -1.68 | -0.36 | 6.78 |
| 2026-07-20 | RVMD | -1.68 | -0.31 | 6.78 |
| 2026-07-21 | RVMD | -1.68 | -0.31 | 6.78 |
| 2026-07-22 | RVMD | -1.68 | -0.31 | 6.78 |
| 2026-07-23 | RVMD | -1.68 | -0.31 | 6.78 |
| 2026-07-24 | RVMD | -1.68 | -0.31 | 6.78 |
| 2026-07-27 | RVMD | -1.68 | -0.31 | 7.37 |
| 2026-07-28 | RVMD | -1.68 | -0.31 | 7.37 |
| 2026-07-29 | RVMD | -1.68 | -0.31 | 7.37 |
| 2026-07-30 | RVMD | -1.68 | -0.31 | 7.37 |
| 2026-07-31 | RVMD | -1.68 | -0.31 | 7.37 |
| 2026-08-03 | RVMD | -1.68 | 0.24 | 7.37 |
| 2026-08-04 | RVMD | -1.68 | 0.24 | 7.37 |
| 2026-08-05 | RVMD | -1.68 | 0.24 | 7.37 |
| 2026-08-06 | RVMD | -1.68 | 0.24 | 7.37 |
| 2026-08-07 | RVMD | -1.68 | 0.24 | 7.37 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-2.34
Avg. EPS Est. Current Quarter
-2.06
Avg. EPS Est. Next Quarter
-1.99
Insider Transactions
-1.68
Institutional Transactions
0.24
Beta
1.4
Average Sales Estimate Current Quarter
17
Average Sales Estimate Next Quarter
7
Fair Value
Quality Score
10
Growth Score
22
Sentiment Score
98
Actual DrawDown %
-1.1
Max Drawdown 5-Year %
-56.9
Target Price
216.4
P/E
Forward P/E
PEG
P/S
P/B
16.86
P/Free Cash Flow
EPS
-8.81
Average EPS Est. Cur. Y
-8.07
EPS Next Y. (Est.)
-5.8
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.63
Return on Equity vs Sector %
-95.2
Return on Equity vs Industry %
-79.1
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.06
EBIT Estimation
◆
RVMD
Healthcare
$205.15
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
67.1
Range 1M
94.6%
Sup Dist
5.2%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-56%
EPS NY
27.9%
52W%
99.1%
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+5.5% upside
Upside
+5.5%
Quality
10
RVMD — P/E HistoricalBiotechnology
Revolution Medicines, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 883
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
RVMD
Latest News
—
Caricamento notizie per RVMD…
stock quote shares RVMD – Revolution Medicines, Inc. Stock Price stock today
news today RVMD – Revolution Medicines, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch RVMD – Revolution Medicines, Inc. yahoo finance google finance
stock history RVMD – Revolution Medicines, Inc. invest stock market
stock prices RVMD premarket after hours
ticker RVMD fair value insiders trading